AT-Patch (ATP-C130/ATP-C70) vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

VX1+

by Volta Medical

AI Verdict

Tool A is designed for continuous, long-term cardiac monitoring and arrhythmia detection, suitable for diagnostic purposes and remote patient management. In contrast, Tool B provides real-time AI-powered assistance to electrophysiologists during cardiac ablation procedures, focusing on identifying abnormal electrograms to guide interventions. They serve different phases of patient care within cardiology.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, non-invasive ambulatory ECG monitoring for patients in their daily lives. This tool is ideal for detecting intermittent arrhythmias over several days or weeks, providing comprehensive data for diagnosis without requiring the patient to remain in a clinical setting.

View AT-Patch (ATP-C130/ATP-C70) →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist seeking real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation or tachycardia. This software helps identify abnormal electrograms to guide more precise ablation, aiming to improve procedural success rates and patient outcomes.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	VX1+
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch prioritizes patient comfort and ease of use with its compact, lightweight, and shower-proof design, requiring no charging or electrode replacement during up to 14 days of continuous monitoring. The accompanying smartphone app further enhances patient usability for live ECG viewing and symptom recording. While VX1+ offers a simple interface for clinicians, AT-Patch's features directly improve the patient experience in a broader, less specialized context.

Clinical Value

VX1+

VX1+ provides real-time AI-powered assistance to electrophysiologists during complex cardiac ablation procedures, directly aiding in the identification of abnormal electrograms. This real-time decision support during a critical interventional procedure has an immediate and direct impact on procedural success and patient outcomes. While AT-Patch offers valuable long-term diagnostic data, VX1+ actively assists in a high-stakes treatment scenario.

Pricing & Value

Tie

Neither AT-Patch nor VX1+ has publicly available pricing information; both typically involve direct sales to medical institutions or distributors. Without any transparent pricing details, it is impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value proposition.

Enterprise Readiness

VX1+

VX1+ explicitly highlights its compatibility and integration with major existing EP recording and 3D mapping systems, such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system. This demonstrates a strong focus on seamless integration into established hospital workflows for specialized procedures. While AT-Patch's analysis software is on-premise, its broader integration capabilities are not detailed.

Innovation

VX1+

VX1+ represents a significant innovation by providing real-time AI-powered guidance during live, complex cardiac ablation procedures, directly influencing critical decision-making in an interventional setting. This application of AI in a high-stakes surgical environment pushes the boundaries of AI in healthcare. AT-Patch's innovation lies in patient-centric remote monitoring and AI-driven diagnostics, which is also valuable but less disruptive in its application.

Support & Docs

Tie

Both products provide evidence of user manuals and documentation. AT-Patch has user manuals for the device and PC software, while VX1+ also has a system user manual. There is no publicly available information to indicate that one offers significantly more extensive support services or documentation than the other.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	VX1+
Name	AT-Patch (ATP-C130/ATP-C70)	VX1+
Company	ATsens Co.	Volta Medical
Tagline	Ambulatory ECG Monitor for Continuous Cardiac Monitoring	Transforming EP Data into AI Solutions
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Surgical AI
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology
Key Features (Primary Function)	Up to 14 days of continuous ECG monitoring with AI analysis for arrhythmia detection.	AI-powered software for real-time identification of abnormal electrograms during cardiac ablation procedures.

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and VX1+.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical application of the AT-Patch compared to VX1+?

The AT-Patch is an ambulatory ECG monitor designed for continuous cardiac monitoring for up to 14 days, primarily for arrhythmia detection. In contrast, VX1+ is AI-powered software that assists electrophysiologists in real-time during cardiac ablation procedures for atrial fibrillation and atrial tachycardia by identifying abnormal electrograms.

How do the AI capabilities of AT-Patch and VX1+ serve different purposes in cardiology?

AT-Patch integrates AI/machine learning algorithms within its AT-Report software for ECG analysis and enhanced arrhythmia detection. VX1+ employs AI-driven insights to assist electrophysiologists in real-time identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures.

Which medical specialties are these tools primarily designed for?

AT-Patch is designed for broader use across Cardiology, Family Medicine, and Internal Medicine for continuous ECG monitoring. VX1+ is specifically tailored for Cardiology, assisting electrophysiologists during cardiac ablation procedures.

What kind of data output or insights can physicians expect from each tool?

AT-Patch provides continuous ECG signal acquisition, live ECG viewing via a smartphone app, symptom recording, and comprehensive reports with AI-powered arrhythmia detection. VX1+ offers real-time manual or automatic annotation of 3D anatomical and electrical maps, identifying dispersed electrograms with color-coded insights to guide ablation procedures.

Do these tools require specific existing hardware or systems to function?

AT-Patch's analysis software is deployed on-premise at medical institutions, working in conjunction with its wearable device. VX1+ requires compatibility with existing 510(k)-cleared catheters and specific data acquisition systems, such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.

What is the patient experience like with each device?

The AT-Patch is a compact and lightweight (13g) wearable device that patients wear for up to 14 days, is shower-proof, and does not require charging or electrode replacement during monitoring. Patients can also use a smartphone app to view live ECG and record symptoms. VX1+ is software used by electrophysiologists during procedures, so patients do not directly interact with the tool itself.